REYON Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	202,851	197,716	235,498	303,360	384,347	631,111
Market Cap Growth	-1.34%	-16.04%	-22.37%	-21.07%	-39.10%	61.64%
Enterprise Value	412,185	403,416	381,553	498,164	550,681	726,725
Last Close Price	11060.00	10780.00	12840.00	16540.00	21444.72	34972.84
PE Ratio	-	-	56.73	84.66	52.23	116.61
PS Ratio	1.39	1.36	1.59	2.01	2.50	4.42
PB Ratio	0.92	0.90	0.94	1.22	1.55	2.57
P/TBV Ratio	0.93	0.90	0.95	1.23	1.56	2.59
P/OCF Ratio	139.26	135.73	-	35.09	44.03	54.01
EV/Sales Ratio	2.82	2.76	2.57	3.30	3.58	5.09
EV/EBITDA Ratio	214.68	1736.25	71.21	76.00	61.31	117.02
EV/EBIT Ratio	-	-	-	281.00	123.81	470.45
Debt / Equity Ratio	0.98	0.98	0.82	0.91	0.85	0.85
Debt / EBITDA Ratio	930.13	930.13	38.08	34.33	23.40	33.38
Net Debt / Equity Ratio	0.95	0.95	0.78	0.81	0.70	0.45
Net Debt / EBITDA Ratio	900.94	900.94	36.18	30.64	19.39	17.69
Net Debt / FCF Ratio	-32.41	-32.41	-11.11	-9.93	-3.20	-1.04
Asset Turnover	0.30	0.30	0.30	0.31	0.32	0.36
Inventory Turnover	2.72	2.72	1.99	2.25	2.60	2.35
Quick Ratio	0.29	0.29	0.35	0.51	1.63	2.91
Current Ratio	0.56	0.56	0.66	0.80	2.27	3.47
Return on Equity (ROE)	-12.60%	-12.60%	1.67%	1.44%	3.02%	2.33%
Return on Assets (ROA)	-4.09%	-4.09%	-0.12%	0.22%	0.58%	0.24%
Return on Invested Capital (ROIC)	-7.27%	-7.23%	-0.18%	0.36%	1.15%	0.49%
Return on Capital Employed (ROCE)	-9.80%	-9.80%	-0.30%	0.50%	1.00%	0.40%
Earnings Yield	-14.61%	-14.99%	1.76%	1.18%	1.93%	0.88%
FCF Yield	-3.18%	-3.27%	-7.41%	-6.67%	-14.16%	-16.68%
Dividend Yield	-	-	-	0.91%	0.70%	0.71%
Payout Ratio	-	-	66.27%	76.41%	61.38%	62.56%
Buyback Yield / Dilution	0.17%	0.17%	-0.15%	-0.46%	-3.03%	-4.05%
Total Shareholder Return	0.17%	0.17%	-0.15%	0.45%	-2.33%	-3.34%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.